Showing results (761-770 of 437,675) with videos related to
Sort By:
Pageof 43,768
The International Journal of Neuropsychopharmacology|January 19, 2023
Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response MarkersPriyanka Singh, Ankit Srivastava, Debleena Guin, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|April 25, 2012
Therapeutic potential of 7,8-dimethoxycoumarin on cisplatin- and ischemia/reperfusion injury-induced acute renal failure in ratsArunachalam Muthuraman, Shailja Sood, Muthusamy Ramesh, et al.Indian Heart Journal|March 4, 2014
A cost effective endovascular approach for management of post-catheterization profunda femoris artery pseudoaneurysm using thrombinBishav Mohan, Gaurav Mohan, Rohit Tandon, et al.Molecular Reproduction and Development|July 16, 2019
RNA sequencing and transcriptome analysis of buffalo (Bubalus bubalis) blastocysts produced by somatic cell nuclear transfer and in vitro fertilizationTanushri Jerath Sood, Swati Viviyan Lagah, Manishi Mukesh, et al.Biosensors & Bioelectronics|July 27, 2015
QCM sensing of melphalan via electropolymerized molecularly imprinted polythiophene filmsAmbareesh Kumar Singh, Meenakshi SinghDiabetes Research and Clinical Practice|August 28, 2020
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19Awadhesh Kumar Singh, Ritu SinghDiabetes Research and Clinical Practice|January 9, 2021
Effect of background insulin therapy on cardiovascular outcomes with SGLT-2 inhibitors in type 2 diabetes: A meta-analysis of cardiovascular outcome trialsAwadhesh Kumar Singh, Ritu SinghCells|February 15, 2022
Cytokines and Chemokines in Cancer Cachexia and Its Long-Term Impact on COVID-19Santosh Kumar Singh, Rajesh SinghDiabetes & Metabolic Syndrome|September 8, 2020
At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19Awadhesh Kumar Singh, Ritu SinghDiabetes & Metabolic Syndrome|March 7, 2020
Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trialsAwadhesh Kumar Singh, Ritu SinghPageof 43,768